233 related articles for article (PubMed ID: 33860478)
1. [Percutaneous local ablation of small renal cell cancer].
Ringe KI
Aktuelle Urol; 2021 Sep; 52(5):445-451. PubMed ID: 33860478
[TBL] [Abstract][Full Text] [Related]
2. Ablation of Small Renal Masses.
Abdelsalam ME; Ahrar K
Tech Vasc Interv Radiol; 2020 Jun; 23(2):100674. PubMed ID: 32591194
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of RFA versus MWA for T1a renal cell carcinoma: a propensity score analysis.
Aarts BM; Gomez FM; Lopez-Yurda M; Bevers RFM; Herndriks J; Beets-Tan RGH; Bex A; Klompenhouwer EG; van der Meer RW
Eur Radiol; 2023 Feb; 33(2):1040-1049. PubMed ID: 36066733
[TBL] [Abstract][Full Text] [Related]
4. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
Andrews JR; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
[TBL] [Abstract][Full Text] [Related]
5. Radiofrequency Ablation, Cryoablation, and Microwave Ablation for T1a Renal Cell Carcinoma: A Comparative Evaluation of Therapeutic and Renal Function Outcomes.
Zhou W; Herwald SE; McCarthy C; Uppot RN; Arellano RS
J Vasc Interv Radiol; 2019 Jul; 30(7):1035-1042. PubMed ID: 30956075
[TBL] [Abstract][Full Text] [Related]
6. Cryoablation for the Treatment of Residual or Recurrent Disease After Prior Microwave Ablation of Renal Cell Carcinoma.
Aarts BM; Baetens TR; Munoz DC; Oudkerk SF; Solouki AM; Horsch AD; Bex A; Beets-Tan RGH; Klompenhouwer EG; Gómez FM
Cardiovasc Intervent Radiol; 2021 Jul; 44(7):1144-1146. PubMed ID: 33723666
[No Abstract] [Full Text] [Related]
7. Available ablation energies to treat cT1 renal cell cancer: emerging technologies.
Zondervan PJ; Buijs M; De Bruin DM; van Delden OM; Van Lienden KP
World J Urol; 2019 Mar; 37(3):445-455. PubMed ID: 30448873
[TBL] [Abstract][Full Text] [Related]
8. The contemporary role of ablative treatment approaches in the management of renal cell carcinoma (RCC): focus on radiofrequency ablation (RFA), high-intensity focused ultrasound (HIFU), and cryoablation.
Klatte T; Kroeger N; Zimmermann U; Burchardt M; Belldegrun AS; Pantuck AJ
World J Urol; 2014 Jun; 32(3):597-605. PubMed ID: 24700308
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous microwave ablation therapy of renal cancer local relapse after radical nephrectomy: a feasibility and efficacy study.
Ierardi AM; Carnevale A; Rossi UG; Renzulli M; Garanzini E; Golfieri R; Macchione N; Cittanti C; Giganti M; Carrafiello G
Med Oncol; 2020 Mar; 37(4):27. PubMed ID: 32166412
[TBL] [Abstract][Full Text] [Related]
10. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
[TBL] [Abstract][Full Text] [Related]
11. Radiofrequency ablation versus cryoablation for T1b renal cell carcinoma: a multi-center study.
Hasegawa T; Yamanaka T; Gobara H; Miyazaki M; Takaki H; Sato Y; Inaba Y; Yamakado K
Jpn J Radiol; 2018 Sep; 36(9):551-558. PubMed ID: 29968201
[TBL] [Abstract][Full Text] [Related]
12. Thermal Ablation of T1c Renal Cell Carcinoma: A Comparative Assessment of Technical Performance, Procedural Outcome, and Safety of Microwave Ablation, Radiofrequency Ablation, and Cryoablation.
Zhou W; Arellano RS
J Vasc Interv Radiol; 2018 Jul; 29(7):943-951. PubMed ID: 29628298
[TBL] [Abstract][Full Text] [Related]
13. A Comparison of Microwave Ablation and Cryoablation for the Treatment of Renal Cell Carcinoma: A Systematic Literature Review and Meta-analysis.
McClure T; Lansing A; Ferko N; Wright G; Ghosh SK; Raza S; Kalsekar I; Clarke K; Talenfeld A
Urology; 2023 Oct; 180():1-8. PubMed ID: 37331485
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Clinical Outcomes Following Radiofrequency and Microwave Ablation of Renal Cell Carcinoma at a Single VA Medical Center.
Abboud SE; Patel T; Soriano S; Giesler J; Alvarado N; Kang P
Curr Probl Diagn Radiol; 2018; 47(2):98-102. PubMed ID: 28648469
[TBL] [Abstract][Full Text] [Related]
15. US-guided percutaneous microwave ablation versus open radical nephrectomy for small renal cell carcinoma: intermediate-term results.
Yu J; Liang P; Yu XL; Cheng ZG; Han ZY; Zhang X; Dong J; Mu MJ; Li X; Wang XH
Radiology; 2014 Mar; 270(3):880-7. PubMed ID: 24475805
[TBL] [Abstract][Full Text] [Related]
16. Cryoablation vs radiofrequency ablation for the treatment of renal cell carcinoma: a meta-analysis of case series studies.
El Dib R; Touma NJ; Kapoor A
BJU Int; 2012 Aug; 110(4):510-6. PubMed ID: 22304329
[TBL] [Abstract][Full Text] [Related]
17. Overall survival and local recurrence following RFA, MWA, and cryoablation of very early and early HCC: a systematic review and Bayesian network meta-analysis.
Gupta P; Maralakunte M; Kumar-M P; Chandel K; Chaluvashetty SB; Bhujade H; Kalra N; Sandhu MS
Eur Radiol; 2021 Jul; 31(7):5400-5408. PubMed ID: 33439319
[TBL] [Abstract][Full Text] [Related]
18. Asian Conference on Tumor Ablation guidelines for renal cell carcinoma.
Park BK; Shen SH; Fujimori M; Wang Y
Investig Clin Urol; 2021 Jul; 62(4):378-388. PubMed ID: 34190433
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous Microwave Ablation of Histologically Proven T1 Renal Cell Carcinoma.
Aarts BM; Prevoo W; Meier MAJ; Bex A; Beets-Tan RGH; Klompenhouwer EG; Gómez FM
Cardiovasc Intervent Radiol; 2020 Jul; 43(7):1025-1033. PubMed ID: 32052093
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous treatment of renal tumours.
Uppot RN; Wah TM; Mueller PR
J Med Imaging Radiat Oncol; 2023 Dec; 67(8):853-861. PubMed ID: 37417722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
